BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Drug Development

  Clearing Up a Misconception: COVID-19 Vaccines and Infertility/Pregnancy Loss

  A study, published recently in the New England Journal of Medicine, demonstrated no obvious safety signals among pregnant persons who received the mRNA vaccines.

  May 14, 2021

   · 

  5 min read

   · 

  Heather McKenzie
• 

  Drug Development

  Humanigen On the Cusp of Filing for Lenzilumab EUA in Hospitalized COVID-19 Patients

  Humanigen reported it had held a meeting with the FDA to discuss plans for filing an EUA for its lenzilumab for hospitalized, hypoxic COVID-19 patients by the end of May.

  May 14, 2021

   · 

  2 min read

   · 

  Mark Terry
• 

  Business

  Biogen’s Gene Therapy Strikes Out in Phase II/III Retinitis Pigmentosa Trial

  Biogen reported that its gene therapy, cotoretigene toliparvovec, failed to hit the primary endpoint of the Phase II/III XIRIUS trial for X-linked retinitis pigmentosa (XLRP).

  May 14, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  Job Trends

  Philadelphia, Pacific Northwest See Surge in Biopharma Jobs

  Life science jobs are booming in several regions around the U.S. One is the Pacific Northwest, specifically Oregon; another is the Philadelphia area. Here’s a look.

  May 14, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  Job Trends

  Biopharma Job Market Booms in Singapore, N.C. and Maryland

  The help wanted signs are up across the biopharma industry. Companies are opening and expanding facilities, which is good news for job seekers.

  May 14, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Genetown

  Cellino Develops Scalable, Closed-Loop System for Autologous Stem Cell Manufacturing

  Cellino’s unique blend of lasers and machine learning is transforming the manufacture of autologous stem cell therapies from an inconsistent hand-crafted endeavor to a scalable, efficient, closed-loop, modern process.

  May 14, 2021

   · 

  4 min read

   · 

  Gail Dutton
• 

  Policy

  Pfizer Commits to Bridging the Diversity Gap in Clinical Trials

  Pfizer’s clinical trials diversity report showed the disproportionate way the virus impacted minority communities in the U.S., increasing the calls for racial and ethnic diversity in clinical studies.

  May 14, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Policy

  Stem Cell Therapy & Research: Possibilities and Challenges

  Stem cell therapy has been available for decades, but the medical field hasn’t fully used its treatment for all applications. In fact, the U.S. FDA has been warning people about using some stem cell therapies and deemed them illegal while others have strict restrictions on their use.

  May 14, 2021

   · 

  4 min read

   · 

  Lorenzo Soliman
• 

  Drug Development

  Interline Will Focus $92 Million Investment to Advance Precision Medicine Platform

  Foresite Labs-incubated company Interline Therapeutics announced Thursday that it had raised $92 million in a financing round co-led by Foresite Capital and ARCH Venture Partners.

  May 14, 2021

   · 

  2 min read

   · 

  Brandon May
• 

  Business

  Report Highlights “Disinformation Dozen” Responsible for Online COVID-19 Vaccine Misinformation

  Overall, the researchers claim this “Disinformation Dozen” generate approximately 65% of the anti-vaccine misinformation on these platforms.

  May 14, 2021

   · 

  3 min read

   · 

  Brandon May